Pregnancy · PPH Prevention
CMQCC PPH Risk Tool
Risk stratification for postpartum haemorrhage. Identifies women needing extra preparation (IV access, blood ready, theatre alerted). Active 3rd stage + tranexamic acid + QBL save lives. RCOG Green-top 52 / CMQCC California.
Last reviewed 2 June 2026
Antepartum / intrapartum PPH risk tier
High-risk factors — ANY ONE = high risk
Medium-risk factors — TWO OR MORE = medium risk
Standard care: active third-stage management with prophylactic oxytocin, routine vital signs, QBL measurement.
What is the CMQCC PPH risk tool?
Risk stratification for postpartum haemorrhage developed by California Maternal Quality Care Collaborative. Stratifies low / medium / high risk. Proactive preparation reduces severe PPH outcomes.
Risk factors
Antenatal:
- Previous PPH.
- Multiple pregnancy.
- Grand multiparity (≥4).
- BMI ≥40.
- Placenta praevia / accreta.
- Uterine fibroids.
- Pre-eclampsia / HELLP.
- Anticoagulation.
- Bleeding disorders.
Intrapartum:
- Prolonged labour.
- Induction + augmentation.
- Chorioamnionitis.
- General anaesthetic.
- Instrumental delivery.
- 3rd/4th degree tears.
Management by risk level
- Low risk: standard care; active 3rd stage; vigilance.
- Medium risk: IV access at admission; type + screen; cross-match available; active 3rd stage.
- High risk: two IV cannulae; cross-matched blood ready; obstetrician + anaesthetist aware; theatre alerted; appropriate consultant-led location; PPH “kit” (TXA, balloon, uterotonics).
Active 3rd stage management
- Prophylactic oxytocin 10 IU IM at anterior shoulder.
- Controlled cord traction.
- Uterine massage.
Reduces PPH ~60%.
Anaemia optimisation
- Target Hb ≥110 g/L by 36+ wk.
- Oral iron first-line (6-8 weeks effect).
- IV iron for persistent low or intolerance.
- Stores (ferritin) matter for recovery.
Placenta accreta / praevia
Highest-risk groups.
- Specialist centre delivery.
- Multidisciplinary team.
- Cell saver, blood products, interventional radiology.
- Plan 34-37 weeks usually.
- May need hysterectomy.
Tranexamic acid
Standard: within 3 hours of PPH onset (WOMAN trial — reduces deaths 19%). Prophylactic in selected very high-risk: emerging practice (TRAAP / TRAAP2 evidence modest).
Future pregnancies
- 10-20% recurrence (varies by cause).
- Correct anaemia preconception.
- Flag as high-risk at booking.
- Consultant-led delivery.
- Theatre + blood products ready.
Different scenarios
Scenario 1: First baby, no risk factors
Low risk. Standard care. Active 3rd stage.
Scenario 2: Previous PPH 1.5L, this pregnancy 36 wk
High risk. Consultant-led. Two IV cannulae. Cross-matched blood. Theatre alerted.
Scenario 3: BMI 42 + twins + induction
High risk multiple factors. Specialist consultant care; intensive preparation.
Scenario 4: Placenta accreta identified antenatally
Specialist centre at 34-37 wk planned. Multidisciplinary team. Cell saver + IR + likely hysterectomy.
Scenario 5: PPH 1L treated, recovering
IV iron. Birth debrief. Mental health support. Future planning consultation.
Care guidance — PPH prevention
- Risk identification at booking + intrapartum.
- Anaemia correction antenatally.
- Active 3rd stage standard.
- QBL measurement.
- TXA within 3h of PPH.
- Multidisciplinary preparation high-risk.
- Birth debrief if traumatic.
- Mental health follow-up.
- Future pregnancies preconception planning.
Sources
- RCOG Green-top Guideline 52. Prevention and management of postpartum haemorrhage.
- CMQCC. California Maternal Quality Care Collaborative PPH toolkit.
- WOMAN Trial Collaborators. Tranexamic acid in PPH. Lancet 2017.
- TRAAP / TRAAP2 trials. Prophylactic tranexamic acid.
Recommended for this calculator